Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Chemoprevention of prostate cancer: Natural compounds, antiandrogens, and antioxidants - In vivo evidence.

Ozten-KandaƟ N, Bosland MC.

J Carcinog. 2011;10:27. doi: 10.4103/1477-3163.90438. Epub 2011 Nov 30.

2.

Executive Summary of the National Cancer Institute Workshop: Highlights and recommendations.

Lieberman R, Nelson WG, Sakr WA, Meyskens FL Jr, Klein EA, Wilding G, Partin AW, Lee JJ, Lippman SM.

Urology. 2001 Apr;57(4 Suppl 1):4-27.

PMID:
11295590
3.

Advances in prostate cancer chemoprevention: a translational perspective.

Nambiar D, Singh RP.

Nutr Cancer. 2013;65 Suppl 1:12-25. doi: 10.1080/01635581.2013.785006. Review.

PMID:
23682779
4.

Molecular mechanisms of silibinin-mediated cancer chemoprevention with major emphasis on prostate cancer.

Ting H, Deep G, Agarwal R.

AAPS J. 2013 Jul;15(3):707-16. doi: 10.1208/s12248-013-9486-2. Epub 2013 Apr 16. Review.

5.

Chemoprevention of prostate cancer: current status and future directions.

Lieberman R.

Cancer Metastasis Rev. 2002;21(3-4):297-309. Review.

PMID:
12549768
6.

A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"?

Gontero P, Marra G, Soria F, Oderda M, Zitella A, Baratta F, Chiorino G, Gregnanin I, Daniele L, Cattel L, Frea B, Brusa P.

Prostate. 2015 Aug 1;75(11):1177-86. doi: 10.1002/pros.22999. Epub 2015 Apr 20.

PMID:
25893930
7.

Dietary agents for chemoprevention of prostate cancer.

Syed DN, Suh Y, Afaq F, Mukhtar H.

Cancer Lett. 2008 Jul 8;265(2):167-76. doi: 10.1016/j.canlet.2008.02.050. Epub 2008 Apr 18. Review.

8.

A Perspective on Prostate Carcinogenesis and Chemoprevention.

Bosland MC, Ozten N, Eskra JN, Mahmoud AM.

Curr Pharmacol Rep. 2015 Aug 1;1(4):258-265. Epub 2015 Apr 11.

9.

Chemoprevention of prostate cancer.

Kucuk O.

Cancer Metastasis Rev. 2002;21(2):111-24. Review.

PMID:
12465750
10.

Chemoprevention of prostate cancer by diet-derived antioxidant agents and hormonal manipulation (Review).

Pathak SK, Sharma RA, Mellon JK.

Int J Oncol. 2003 Jan;22(1):5-13. Review.

PMID:
12469179
11.

Prostate cancer chemoprevention: current status and future prospects.

Gupta S.

Toxicol Appl Pharmacol. 2007 Nov 1;224(3):369-76. Epub 2006 Nov 15. Review.

PMID:
17189645
12.
13.

Agents, biomarkers, and cohorts for chemopreventive agent development in prostate cancer.

Kelloff GJ, Lieberman R, Steele VE, Boone CW, Lubet RA, Kopelovich L, Malone WA, Crowell JA, Higley HR, Sigman CC.

Urology. 2001 Apr;57(4 Suppl 1):46-51.

PMID:
11295594
14.

Update on prostate cancer chemoprevention.

Lowe JF, Frazee LA.

Pharmacotherapy. 2006 Mar;26(3):353-9. Review.

PMID:
16503715
15.

Update on chemoprevention of prostate cancer.

Klein EA, Thompson IM.

Curr Opin Urol. 2004 May;14(3):143-9. Review.

PMID:
15069304
16.

Can we prevent prostate cancer? Rationale and current status of prostate cancer chemoprevention.

Fujimoto N, Chang C, Nomura M, Matsumoto T.

Urol Int. 2005;74(4):289-97. Review.

PMID:
15897691
17.
18.

Chemoprevention of bladder cancer.

Kamat AM, Lamm DL.

Urol Clin North Am. 2002 Feb;29(1):157-68. Review.

PMID:
12109342
19.

An update on chemoprevention strategies in prostate cancer for 2006.

Neill MG, Fleshner NE.

Curr Opin Urol. 2006 May;16(3):132-7. Review.

PMID:
16679848
20.

Null activity of selenium and vitamin e as cancer chemopreventive agents in the rat prostate.

McCormick DL, Rao KV, Johnson WD, Bosland MC, Lubet RA, Steele VE.

Cancer Prev Res (Phila). 2010 Mar;3(3):381-92. doi: 10.1158/1940-6207.CAPR-09-0176. Epub 2010 Feb 9.

Supplemental Content

Support Center